Deletion of EEPD1 reveals macrophage-specific changes in lipid metabolism and cholesterol efflux


Just in before the PhD defence, Suzanne latest publication on EEPD1 was accepted for publication in “Atherosclerosis” (https://www.atherosclerosis-journal.com/article/S0021-9150(25)00060-7/fulltext). This study describes the metabolic phenotype of mice and macrophages lacking EEPD1. This study reveals that mice lacking EEPD1 are susceptible to weight gain when challenged with a fat containing diet, cements the role of EEPD1 in cholesterol efflux, and identifies marked lipidomic changes in macrophages in the absence of EEPD1. 

Share this message

Latest news Medical Biochemistry Amsterdam

By duda-wsm May 28, 2025
At the annual Dutch Atherosclerosis Society (DAS) meeting, Lobke received the award for Best Flash Talk for her presentation on the role of LXR in macrophage immune activation, while Ricky was awarded Best Poster Presentation for his work on the role of IRF1 in macrophage function. Congratulations to both!
By duda-wsm May 23, 2025
Ricky Siebeler won the best presentation award on the annual Amsterdam institute for Immunology and Infectious diseases (AII) symposium for his presentation on Endogenous Retroviral Elements as regulators of macrophage activation. Congratulations!!
Show More